In a cohort of TRANSCEND FL, the chimeric antigen receptor T-cell therapy liso-cel showed a 95% overall response rate in relapsed marginal zone lymphoma, offering hope for improved patient outcomes in ...

251601 Introduction: The differential uptake of FDG observed in early and delayed scans during dual time-point imaging of organs such as the liver and spleen has the potential to significantly impact ...

This lymphoma tends to be slow growing (although not usually as slow as MALT lymphoma), and it’s treated similarly to follicular lymphoma. Splenic marginal zone B-cell lymphoma: This is a rare ...

It's more aggressive than other types of HL and likely to be advanced when first found. It's most often in lymph nodes in the abdomen (belly) as well as in the spleen, liver, and bone marrow. Nodular ...

Like many cancers, mantle cell lymphoma can vary in how quickly it develops and its severity. As Szubanski’s cancer has been described as “fast-moving” and is already stage four, it appears ...